E03.2 Hypothyroidism due to medicaments and other exogenous substances

The ICD-10-CM code for Hypothyroidism due to medicaments and other exogenous substances is E03.2 (FY2026). It is a billable, claim-ready diagnosis code.

Classification

Chapter

4: Endocrine, nutritional and metabolic diseases (E00-E89)

Section

E00-E07: Disorders of thyroid gland (E00-E07)

Category E03

9 codes (8 billable)

FY2026 Status

Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to E03.2:

• Hypothyroidism (acquired) › iatrogenic NEC
• Hypothyroidism (acquired) › due to › sulfonamide
• Hypothyroidism (acquired) › due to › thiourea group drugs
• Hypothyroidism (acquired) › due to › medicament NEC
• Hypothyroidism (acquired) › due to › exogenous substance NEC
• Hypothyroidism (acquired) › due to › P-aminosalicylic acid (PAS)
• Hypothyroidism (acquired) › due to › resorcinol
• Hypothyroidism (acquired) › due to › phenylbutazone

U.S. Hospital Utilization

• An estimated 8,860 U.S. inpatient stays in 2023 included E03.2 among the documented diagnoses.
• 285 stays listed it as the principal diagnosis.

Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.

Official Coding Guidelines

Diabetes mellitus (TOC entry)

a. Diabetes mellitus ................................................................................................................... 39

Obesity (TOC entry)

b. Obesity .................................................................................................................................. 42

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

• CMS — ICD-10-CM Official Code Set and Guidelines, FY2026
• CDC/NCHS — ICD-10-CM Files and Browser Tool
• AHRQ — HCUP National Inpatient Sample, Frequencies by Diagnosis Code (2016–2023)